A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation ...
MENLO PARK, Calif. - Octave Bioscience announced Monday a strategic collaboration with Quest Diagnostics (NYSE:DGX) to make its Multiple Sclerosis Disease Activity (MSDA) Test available through ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Octave Bioscience, Inc., a commercial-stage precision care company pioneering biomarker-driven solutions for multiple sclerosis (MS) and other neurodegenerative ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する